LLY
Eli Lilly and Company
1,142.90$
-0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 19.6% | 19.1% | 19.1% | 19.2% | 19.0% | 17.8% | 17.5% | 15.7% | 17.1% | 17.5% | 18.1% | 14.2% | 16.6% | |
| 80.4% | 80.9% | 80.9% | 80.8% | 81.0% | 82.2% | 82.5% | 84.3% | 82.9% | 82.5% | 81.9% | 85.8% | 83.4% | |
| 25.4% | 27.4% | 28.8% | 24.0% | 23.9% | 22.3% | 21.5% | 21.4% | 19.7% | 19.7% | 17.7% | 16.6% | 18.3% | |
| 17.8% | 19.3% | 20.9% | 17.7% | 17.3% | 17.1% | 18.6% | 17.0% | 15.6% | 17.3% | 14.8% | 14.9% | 15.6% | |
| 43.1% | 46.7% | 49.7% | 41.7% | 41.2% | 39.4% | 40.0% | 38.5% | 35.3% | 35.9% | 32.5% | 31.6% | 33.7% | |
| 37.3% | 34.1% | 31.2% | 39.1% | 39.8% | 42.8% | 42.5% | 45.8% | 47.6% | 46.6% | 49.4% | 54.2% | 49.7% | |
| 1.3% | 1.5% | 2.0% | 1.6% | 1.7% | 1.7% | 1.9% | 1.6% | 1.0% | 0.6% | 1.7% | 1.5% | 1.2% | |
| 4.5% | 26.8% | 28.9% | 31.1% | 13.9% | 37.2% | 27.2% | 43.6% | 41.1% | 42.8% | 44.7% | 40.2% | 42.2% | |
| 5.1% | 3.4% | 3.3% | 4.9% | 5.4% | 4.6% | 5.5% | 7.2% | 9.4% | 8.4% | 7.3% | 9.4% | 8.6% | |
| -0.6% | 23.4% | 25.6% | 26.3% | 8.5% | 32.6% | 21.7% | 36.4% | 31.7% | 34.4% | 37.4% | 30.9% | 33.5% | |
| 10.1% | 32.4% | 35.5% | 36.4% | 19.7% | 42.5% | 32.7% | 48.2% | 44.8% | 63.0% | 52.0% | 56.5% | 54.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.